Streetbeat News

Price Targets

AVB

RBC Capital analyst Michael Carroll has reiterated a 'Sector Perform' rating on AvalonBay Communities (AVB) and maintained a price target of $185.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:33 pm

ALGN

Goldman Sachs analyst Nathan Rice maintains a Sell rating on Align Technology (NASDAQ:ALGN) but raises the price target from $197 to $225.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:31 pm

BALL

RBC Capital analyst Arun Viswanathan has maintained a 'Sector Perform' rating on Ball Corporation (NYSE:BALL) and increased the price target from $51 to $61.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:28 pm

ACET

HC Wainwright & Co. analyst Edward White maintains a Buy rating on Adicet Bio (NASDAQ:ACET) but lowers the price target from $26 to $10.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:27 pm

TECH

RBC Capital analyst Conor McNamara has maintained a 'Sector Perform' rating on Bio-Techne (NASDAQ:TECH) but lowered the price target from $85 to $75.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:26 pm

TXN

Cantor Fitzgerald analyst C J Muse has reiterated a Neutral rating on Texas Instruments (NASDAQ:TXN) and maintained a $170 price target.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:15 pm

ACAD

Cantor Fitzgerald analyst Charles Duncan reiterated an Overweight rating on ACADIA Pharmaceuticals (ACAD) and maintained a $42 price target.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:13 pm

ELV

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Elevance Health (NYSE:ELV) and maintained a price target of $547.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:09 pm

INTC

Cantor Fitzgerald analyst C J Muse has reiterated a Neutral rating on Intel (NASDAQ:INTC) and maintained a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:05 pm